Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared a post on LinkedIn:
“Congratulations to Azza Sarfraz on her first presentation since joining the GI cancer research team at Miami Cancer Institute, presented at the American Society of Clinical Oncology (ASCO) GI26 Symposium. Excellent collaborative work on checkpoint inhibitors in neuroendocrine tumors—certainly the first of many more to come.
Kudos as well to all the co-authors.”
More posts featuring Sarbajit Mukherjee.